21
NPS Score
VS
Gilead Sciences Claimed Company
- EMPLOYEE
PARTICIPANTS - 216
- TOTAL
RATINGS
Pharmacyclics
- EMPLOYEE
PARTICIPANTS - 7
- TOTAL
RATINGS
Gilead Sciences vs Pharmacyclics
Compare Gilead Sciences versus Pharmacyclics for CEO Rating, Overall Culture Score, Brand Ranking, and other ratings. Results were generated by 216 employees and customers of Gilead Sciences and 7 employees and customers of Pharmacyclics.
Gilead Sciences
Gilead Sciences's brand is ranked #478 in the list of Global Top 1000 Brands, as rated by customers of Gilead Sciences. Their current market cap is $83.65B.
Pharmacyclics
Pharmacyclics's brand is ranked #- in the list of Global Top 1000 Brands, as rated by customers of Pharmacyclics.
3.7/5
Product Quality
1.5/5
3.6/5
Pricing
N/A
3.9/5
Customer Service
N/A
| 51% | Promoters |
|---|---|
| 19% | Passive |
| 30% | Detractors |
Net Promoter Score
Winner by 121
-100
NPS Score
| 0% | Promoters |
|---|---|
| 0% | Passive |
| 100% | Detractors |
See how Pharmacyclics compares to its competitors
Working at Gilead Sciences vs Working at Pharmacyclics
68 / 100
CEO Rating
Winner by 8%
60 / 100
CEO Rating
Gilead Sciences
Gilead Sciences doesn't have enough ratings to calculate the Team Culture Ratings.
Know someone that works there? Invite them to rate their experience.
Pharmacyclics
Employees at Pharmacyclics rate their CEO, , 60/100. This score is 8% lower than the scores of Gilead Sciences' CEO, Daniel O’Day.